Yu-hsuan Hung
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Inhibition of Cyclin-dependent Kinase Counteracts Neuron-promoted Bladder and Endometrial Tumorigenesis: A Systematic Analysis.
Journal: In vivo (Athens, Greece)
Published: April 03, 2026
Transcriptomic Profiling Identifies Higher DOT1L Expression as a Candidate Biomarker for a Positive Response to Gemcitabine in Cholangiocarcinoma.
Journal: Cancer genomics & proteomics
Published: March 02, 2026
Ubiquitin Ligase RNF149 Promotes Head and Neck Cancer Growth via Downregulation of CDKN2C.
Journal: Anticancer research
Published: February 07, 2026
Ubiquitin-specific Peptidase 53 Suppresses Head/Neck Tumorigenesis by Stabilizing FBXW7.
Journal: Anticancer research
Published: January 27, 2026
Immunotherapy Response Predictive Score Based on Tumor Microenvironment Profiles for Predicting Immunotherapy Outcomes in Advanced Head and Neck Cancer.
Journal: Technology in cancer research & treatment
Published: January 23, 2026
Mutant Isocitrate Dehydrogenase 1 Sensitizes Intrahepatic Cholangiocarcinoma Cells to MDM2 Inhibitors.
Journal: Cancer research communications
Published: September 26, 2025
Exploring the characteristics of the SKP2-CDK6 axis in pancreatic cancer cell metastasis and its clinical significance.
Journal: Experimental and molecular pathology
Published: August 13, 2025
Adipocyte-driven STAT3-ANGPT2-PTGIS axis promotes cutaneous metastasis in breast cancer and represents a targetable pathway.
Journal: NPJ precision oncology
Published: July 29, 2025
Targeting the CDK7-MDK axis to suppresses irinotecan resistance in colorectal cancer.
Journal: Life sciences
Published: May 25, 2024
Chromatin Remodeling-Related PRDM1 Increases Stomach Cancer Proliferation and Is Counteracted by Bromodomain Inhibitor.
Journal: Journal of personalized medicine
Published: January 11, 2024
Neuron-derived neurotensin promotes pancreatic cancer invasiveness and gemcitabine resistance via the NTSR1/Akt pathway.
Journal: American journal of cancer research
Published: November 10, 2023
RNF43 Inactivation Enhances the B-RAF/MEK Signaling and Creates a Combinatory Therapeutic Target in Cancer Cells.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 16, 2023
Last Updated: 09/26/2026